Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04394715 · ClinicalTrials.gov registry record · NA
Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 2,596
- Enrollment target
NCT04394715 is a NA study that has completed, run by Yale University. The registered enrollment target is 2,596 participants.
The verdict
NCT04394715, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,596 participants
- Enrollment target
Study Summary
This study is designed to evaluate the efficacy of automated electronic alerts in the electronic health record to improve rates of best practices in the treatment of patients with hyperlipidemia who present in the setting of outpatient primary care and family medicine practices within the Yale New Haven Health System.
Interventions
- OTHER Electronic Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,596 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04394715
The ClinicalTrials.gov registry entry for NCT04394715 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,596 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electronic Alert is the first listed.
NCT04394715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04394715 about?
NCT04394715 is a clinical study titled "Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)". This study is designed to evaluate the efficacy of automated electronic alerts in the electronic health record to improve rates of best practices in the treatment of patients with hyperlipidemia who present in the setting of outpatient primary care and family medicine practices within the Yale New H...
What is the current status of trial NCT04394715?
This trial is currently completed. It is a NA study. The enrollment target is 2,596 participants. The study started on 2021-06-01. Estimated completion is 2022-09-09.
What interventions are being tested in trial NCT04394715?
The interventions under investigation include: Electronic Alert (OTHER).
Who is sponsoring clinical trial NCT04394715?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.